Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
40.5M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
20.3M
-
Shares change
-
-7.7K
-
Total reported value, excl. options
-
$519M
-
Value change
-
+$4.15M
-
Number of buys
-
100
-
Number of sells
-
-88
-
Price
-
$25.54
Significant Holders of PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) as of Q2 2025
213 filings reported holding PAHC - PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share as of Q2 2025.
PHIBRO ANIMAL HEALTH CORP - Class A Common Stock, par value $0.0001 per share (PAHC) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.3M shares
of 40.5M outstanding shares and own 50.13% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.49M shares), VANGUARD GROUP INC (1.55M shares), STATE STREET CORP (909K shares), ACADIAN ASSET MANAGEMENT LLC (724K shares), ExodusPoint Capital Management, LP (680K shares), RENAISSANCE TECHNOLOGIES LLC (611K shares), DIMENSIONAL FUND ADVISORS LP (557K shares), GEODE CAPITAL MANAGEMENT, LLC (555K shares), CastleKnight Management LP (531K shares), and MORGAN STANLEY (492K shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.